Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Synergism between Apple Procyanidins and Lysosomotropic Drugs: Potential in Chemoprevention

NIKOLAUS SEILER, MEHDI CHAABI, STAMATIKI ROUSSI, FRANCINE GOSSÉ, ANNELISE LOBSTEIN and FRANCIS RAUL
Anticancer Research September 2006, 26 (5A) 3381-3385;
NIKOLAUS SEILER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nikolaus.seiler{at}ircad.u-strasbg.fr
MEHDI CHAABI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STAMATIKI ROUSSI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCINE GOSSÉ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNELISE LOBSTEIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANCIS RAUL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Procyanidins are apple constituents with potential in colon cancer chemoprevention. Materials and Methods: Human colon cancer derived metastatic cells (SW620), growing under standardized conditions, were exposed to procyanidins and lysosomotropic compounds. Growth, apoptosis and lysosomal integrity was determined using published methods. Results: Lysosomotropic drugs (MDL 72527, phenylalanine methylester and chloroquine) amplified procyanidin-induced growth inhibition and apoptosis in SW620 cells at non-cytotoxic concentrations. The improved toxicity of the drug combinations relies primarily on the enhancement of lysosomal membrane permeability. Conclusion: Combinations with non-toxic concentrations of lysosomotropic compounds improve the anti-carcinogenic properties of apple procyanidins.

  • Procyanidins
  • chloroquine
  • MDL 72527
  • phenylalanine methylester
  • lysosomes
  • cytotoxicity
  • SW 620 cells

Footnotes

  • Received April 28, 2006.
  • Accepted June 21, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 5A
September-October 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synergism between Apple Procyanidins and Lysosomotropic Drugs: Potential in Chemoprevention
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Synergism between Apple Procyanidins and Lysosomotropic Drugs: Potential in Chemoprevention
NIKOLAUS SEILER, MEHDI CHAABI, STAMATIKI ROUSSI, FRANCINE GOSSÉ, ANNELISE LOBSTEIN, FRANCIS RAUL
Anticancer Research Sep 2006, 26 (5A) 3381-3385;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Synergism between Apple Procyanidins and Lysosomotropic Drugs: Potential in Chemoprevention
NIKOLAUS SEILER, MEHDI CHAABI, STAMATIKI ROUSSI, FRANCINE GOSSÉ, ANNELISE LOBSTEIN, FRANCIS RAUL
Anticancer Research Sep 2006, 26 (5A) 3381-3385;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Musashi1 Enhances Cell Growth and Increases Chemoresistance in Neuroblastoma
  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire